D9421-C

· AstraZeneca

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for D9421-C, covering 2012-02-24 to 2016-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan [Phase 3]